Navigation Links
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
Date:12/10/2008

The above mentioned studies and data represent the latest results of clinical research for each treatment and are not necessarily part of the indicated licence in each country. For detailed label information, visit the website of your health authority or the EMEA website http://www.emea.europa.eu/

Note to Editors

Breast cancer is the most common cancer among women worldwide.(i) Each year more than one million new cases of breast cancer are diagnosed worldwide, and nearly 400,000 people will die of the disease annually. (ii) In HER2- positive breast cancer, increased quantities of the HER2 protein are present on the surface of the tumour cells. This is known as 'HER2-positivity'. High levels of HER2 are present in a particularly aggressive form of the disease which responds poorly to chemotherapy. Research shows that HER2-positivity affects approximately 20-30 percent of women with breast cancer.(iii)

About Roche

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the

central nervous system. In 2007 sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances with numerous
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
6. Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
7. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/6/2015)... , March 6, 2015 Lucerne Biosciences, ... Office,s publication of U.S. Patent Application No. 14/464,249 ... Patent Application features claimed methods of "informing a ... to treat Binge Eating Disorder (,BED,)," including by ... "flyer or an advertisement," as well as by ...
(Date:3/5/2015)... , March 5, 2015 BioLineRx (NASDAQ: ... biopharmaceutical company dedicated to identifying, in-licensing and developing ... commenced an underwritten public offering of American Depositary ... Ordinary Shares. All of the ADSs in the ... JMP Securities is acting as sole ...
(Date:3/5/2015)...  IRIDEX Corporation (Nasdaq: IRIX ) today reported ... 3, 2015.  , Revenues were $11.8 million in ... and up 11% from $10.6 million in the 2013 fourth ... up 12% from $38.3 million in 2013. , Gross ... 48.6% in the fourth quarter of the prior year. ...
Breaking Medicine Technology:Lucerne Biosciences Announces Publication of Claimed Methods for Treating Binge Eating Disorder with Lisdexamfetamine Dimesylate 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 2BioLineRx Announces Underwritten Public Offering of its American Depositary Shares 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 2IRIDEX Reports 2014 Fourth Quarter, Year-End Results 3IRIDEX Reports 2014 Fourth Quarter, Year-End Results 4IRIDEX Reports 2014 Fourth Quarter, Year-End Results 5IRIDEX Reports 2014 Fourth Quarter, Year-End Results 6IRIDEX Reports 2014 Fourth Quarter, Year-End Results 7IRIDEX Reports 2014 Fourth Quarter, Year-End Results 8
... ... 15 SRI International, an independent nonprofit research and development organization, ... bioadhesive drug delivery system that enables enhanced release of drugs through ... drug delivery and allows for a much longer release time compared ...
... , KNOXVILLE, Tenn., Dec. 15 Medical researchers with EDP ... new technology for a simple blood test to detect early-stage ... pre-clinical trials for the ColoMarker(TM) assay, EDP has filed a ... use. Via an inexpensive blood test, ColoMarker(TM) will detect ...
Cached Medicine Technology:SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 2SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 3SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 4SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System 5Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2
(Date:3/6/2015)... 06, 2015 Los Angeles cosmetic dentist ... for Zoom whitening. Zoom is a special type of teeth ... Unlike other teeth whitening treatments, Zoom does its job in ... stains. For a limited time, Dr. Ghasri is offering Zoom ... usual price of $650 and allows patients to try out ...
(Date:3/6/2015)... March 06, 2015 Medical Products, Inc., ... an agreement with GE Healthcare to become an authorized ... United States. , MPI has 31 years in distribution ... Healthcare. , With this agreement, MPI will have the ... the healthcare industry. , MPI has always strived ...
(Date:3/5/2015)... (PRWEB) March 06, 2015 In 2014, ... being first–in-class. AstraZeneca tops the list scoring 4 drug ... over 25% of all FDA approved drug products, followed ... mechanisms such as anti-PCSK9, anti-PD1 and CDK inhibitors keep ... approved by the FDA to treat metastatic melanoma, and ...
(Date:3/5/2015)... March 05, 2015 A Bakersfield, Calif. state ... seven-week trial awarding the plaintiff Coleen M. Perry a ... result of a TVT-Abbrevo pelvic mesh sling device, manufactured by ... Tom Cartmell , a partner at Wagstaff & Cartmell ... for the plaintiff, along with Rich Freese and Tim Goss ...
(Date:3/5/2015)... Central Nebraska Imaging (CNI) is pleased to ... new logo and optimized website. , CNI’s ... to expert diagnostic imaging, centered on patient care. The ... be a resource for Nebraska patients and a tool ... and referral functionality, video content and resources to understand ...
Breaking Medicine News(10 mins):Health News:Los Angeles Cosmetic Dentist, Dr. Poneh Ghasri, is Now Offering a Promotion on Zoom Whitening 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 2Health News:World Pharma Business and Large-Cap Companies Discussed by MP Advisors in In-demand Study Available at MarketPublishers.com 3Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Central Nebraska Imaging Center Gets Rebranding 2
... A study of 62 youngsters has revealed that low tar, ... severely as regular cigarettes . ,All the participants ... Heart, were in their mid-twenties. ,Twenty of them ... three years, while 20 other participants had smoked regular cigarettes ...
... A new research has found that extremely anxious patients with ... or death when compared to those with a calmer ... time were in greatest danger, while those who initially had ... their risk. ,"Most patients come in very anxious ...
... a solution for the embarrassing problem of bad breath or ... paste that can tackle separate causes of smelly breath. ... dihydrogen sulphide, which can lead to bad breath, reports the ... enzyme that fights starch and cellulose in between the teeth ...
... have higher dietary intake of foods with omega-3 fatty acids ... age-related macular degeneration, while those with higher serum levels ... early stages of the disease, according to two reports in ... JAMA/Archives journals. ,Age-related macular degeneration (AMD) occurs when ...
... surgical removal of the prostate due to cancer may ... not worry about the post-surgical urinary incontinence. ... at NewYork-Presbyterian Hospital/Weill Cornell Medical Center has devised a ... ensure continence. ,They describe the success of ...
... to take a heavy toll the world over. Almost 100 million ... as infants. ,According to a searing report on the ... the increase in many developing countries, where a male child ... International - a global child development agency - highlights the fact ...
Cached Medicine News:Health News:Risk of Heart Attack, Death High Among Extremely Anxious Patients 2Health News:Risk of Heart Attack, Death High Among Extremely Anxious Patients 3Health News:Higher Intake of Fish and Vitamin D Reduces the Risk of Age-related Macular Disease 2Health News:Higher Intake of Fish and Vitamin D Reduces the Risk of Age-related Macular Disease 3Health News:Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy 2Health News:Innovative Procedure Helps Men Minimize Incontinence After Prostatectomy 3Health News:Female Infanticide and Feticide Continue to Increase 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: